Wczytywanie spółki
Just reported
Q4 FY2026 results
From Becton, Dickinson's results release of 5 listopada 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Revenue
Actual
5,27B USD
-36% y/y
+5,8% q/qGuided
—
No guide given
EPS, GAAP
Actual
2,54 USD
+48% y/y
+85% q/qGuided
—
No guide given
EPS, adjusted: 2,52 USD
Operating income, GAAP
Actual
1,03B USD
-12% y/y
+56% q/qGuided
—
No guide given
Company outlook
Full year 2027
- EPS, adjusted13,10 USD – 13,30 USDFirst given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Becton, Dickinson is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The theme it is part of
Highest-graded in Medical Instruments and Supplies
Graded A or B and worth $2B or more: A first, then the largest.
ISRGIntuitive Surgical, Inc.152,5B USDA+
MDLNMedline Inc.52,6B USDA
ALCAlcon Inc.35B USDA
BLCOBausch & Lomb Corp7,6B USDA-
ATRCAtriCure, Inc.2,9B USDA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation21 paź 2026CBGraded C, now B
MCKMckesson Corporation4 lis 2026BAGraded B, now A
CVSCVS Health Corp4 lis 2026BAGraded B, now A
EWEdwards Lifesciences Corporation4 lis 2026BAGraded B, now A
BIIBBiogen Inc.28 paź 2026BAGraded B, now A
Pełne sprawozdania finansowe →
Zbudowane z własnych raportów spółki Becton, Dickinson And Company składanych do amerykańskiej Komisji Papierów Wartościowych i Giełd (SEC). Liczby są takie, jak zaraportowano, a historia na akcję przeliczona na dzisiejszą bazę akcji. To opisuje firmę — nie jest poradą inwestycyjną ani rekomendacją kupna lub sprzedaży.
